Advances in Clinical and Experimental Medicine

Journal Metrics
(Based on the publications from the last 4 years)
(from 2020-11-01 to roughly 2024-11-01)
Number of papers692
H4-Index18
TQCC4
Average citations3.172
Median citations1
Impact Factor2.100 (based on Web of Science 2023)
Twitter@in_clinical (ca. 8 followers)

(API-Link)

Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
Impactful Papers
(Based on publications since 2023; last updated 2024-10-19)
Altmetric Attention Score: 15
Unleashing the power of anti-CD20 immunotherapy: Mitigating multiple sclerosis risk in Epstein–Barr virus latent infections
Advances in Clinical and Experimental Medicine 2023-12-16
Altmetric Attention Score: 14
Lecanemab (Leqembi) is not the right drug for patients with Alzheimer’s disease
Advances in Clinical and Experimental Medicine 2023-09-11
Altmetric Attention Score: 14
Donanemab: Not two without a third
Advances in Clinical and Experimental Medicine 2023-10-17
Altmetric Attention Score: 12
Helicobacter pylori infection is associated with increased accumulation of advanced glycation end products in the skin in patients with type
Advances in Clinical and Experimental Medicine 2023-03-07
Altmetric Attention Score: 7
Evaluating the effects of glucagon-like peptide-1 receptor agonists on cognitive function in Alzheimer’s disease: A systematic review and me
Advances in Clinical and Experimental Medicine 2023-04-21
Ad
0.0059051513671875